The US FDA says that it has recently become aware of cases of thrombotic thrombocytopenic purpura (TTP) in individuals abusing Opana ER

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1425, 2012-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutations of factor H (HF) in familial Hemolytic Uremic Syndrome (HUS) / Thrombotic Thrombocytopenic Purpura (TTP)

By Caprioli J.   Bettinaglio P.   Zipfel P.F.   Vasile B.   Gamba S.   Amadei B.   Orisio S.   Remuzzi G.   Noris M.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 13-13

Elsevier

Access to resources Recommend Favorite

Clopidogrel linked with thrombotic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Investigational drugs in thrombotic thrombocytopenic purpura

By Noris Patrizia   Balduini Carlo L  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1087-1098

Informa Healthcare

Access to resources Recommend Favorite

Rifampicin: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Tacrolimus: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1211, 2008-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite